QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead

Abbott

Status: Completed

Conditions: Heart Failure

Study type: Observational

Funder types: Industry

Identifiers

NCT01733368

CR-1 2-015-SP-HF

Details and patient eligibility

About

Optimization and evolution of the patient will be evaluated over 6 months after the implant.

Full description

Patient will be enrolled into the study after Informed Consent signature and CRT-D+quadripolar (QuartetTM) LV lead.

Enrollment: 198 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with implanted CRT-D device and a QuartetTM quadripolar lead by St. Jude Medical in the left ventricle.
• Patient with an echocardiographic study performed during 1 month prior to the implant and in whom End Systolic Volume of the Left Ventricle (LVESV) has been measured
• Patients who have granted their informed consent.
• Patients above 18 years.

Exclusion criteria

• Patients that have been previously resynchronized.
• Patients with aortic stenosis or aortic valve prosthesis
• Patients who are or may potentially be pregnant.
• Patients with a life expectancy <12 months.
• Patients who cannot attend the monitoring visits established by the protocol.